Denali Therapeutics (DNLI) Capital Expenditures (2017 - 2026)
Denali Therapeutics (DNLI) reported Capital Expenditures of $805,000 for Q2 2026, down 81.2% from $4.28 million a year earlier and down 67.4% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Capital Expenditures (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Denali Therapeutics' Capital Expenditures came in at $3.42 million, down 81.4% year-over-year; for FY2025, it was $9.5 million, down 40.3% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $15.91 million in FY2024 (+23.0%), $12.94 million in FY2023 (-27.4%), $17.83 million in FY2022 (+109.8%) and $8.5 million in FY2021 (+174.6%).
- Five-year quarterly Capital Expenditures spans a low of -$1.38 million in Q3 2025 and a high of $6.05 million in Q3 2022.
- Year over year, Capital Expenditures has now declined in each of the last three quarters, with growth averaging 19.8% over the last seven quarters.
- The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 274.7%); the low point was Q2 2026 (a decline of 81.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.47 million (Q1 2026), $1.52 million (Q4 2025) and -$1.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.80 Bn | 1,100.39 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 614.01 Bn | 532.53 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.59 Bn | 476.70 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.81 Bn | 261.80 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.50 Bn | 235.19 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.24 Bn | 191.64 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Denali Therapeutics | 3.54 Bn | 121.32 Mn | 3.51 Mn | 805,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 805,000.00 |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | -1.38 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | 5.08 Mn |
| Dec 31, 2024 | 5.09 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 5.85 Mn |
| Mar 31, 2023 | 2.79 Mn |
| Dec 31, 2022 | 4.85 Mn |
| Sep 30, 2022 | 6.05 Mn |
| Jun 30, 2022 | 2.89 Mn |
| Mar 31, 2022 | 4.04 Mn |
| Dec 31, 2021 | 3.05 Mn |
| Sep 30, 2021 | 1.88 Mn |
API Access
Denali Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();